AbCellera Biologics (ABCL) EBITDA Margin Growth (1y) (2021 - 2026)
AbCellera Biologics (ABCL) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
AbCellera Biologics |
1.55 Bn |
1.44 Bn |
- |
64,181.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
64,181.00 |
| Dec 31, 2025 |
71,636.00 |
| Sep 30, 2025 |
13,419.00 |
| Jun 30, 2025 |
32,995.00 |
| Mar 31, 2025 |
-73,016.00 |
| Dec 31, 2024 |
-22,322.00 |
| Sep 30, 2024 |
-34,559.00 |
| Jun 30, 2024 |
-20,544.00 |
| Mar 31, 2024 |
-7,479.00 |
| Dec 31, 2023 |
-37,463.00 |
| Sep 30, 2023 |
-45,188.00 |
| Jun 30, 2023 |
-28,713.00 |
| Mar 31, 2023 |
-38,756.00 |
| Dec 31, 2022 |
-18,464.00 |
| Sep 30, 2022 |
44,053.00 |
| Jun 30, 2022 |
-1,462.00 |
| Mar 31, 2022 |
-441.00 |
| Dec 31, 2021 |
-1,351.00 |
| Sep 30, 2021 |
-38,678.00 |
| Jun 30, 2021 |
-6,032.00 |
